- AMP
- Published:
Risque viral lié au virus de l’hépatite C en AMP
Transmission risk of c hepatitis virus in assisted reproductive techniques
Andrologie volume 10, pages 58–65 (2000)
Résumé
Nous sommes amenés à prendre en charge en assistance médicale à la procréation (AMP) un nombre croissant de couples dont l’un ou les deux partenaires présente (nt) une infection au virus de l’hépatite C (VHC). Le risque, jusqu’ici théorique, est la transmission du virus à l’enfant conçu en AMP, puis à sa mère, mais aussi celui de la contamination du personnel manipulant les gamètes infectés, ou des gamètes et embryons des couples noninfectés. Dans le but de mieux apprécier le risque de transmission du VHC en AMPvia le sperme d’un patient infertile virémique, nous avons recherché le virus de l’hépatite C (ARN VHC) par amplification génique (RT-PCR) dans le sperme et les différentes fractions obtenues après gradient de centrifugation. La recherche de l’ARN du VHC dans le sperme s’est révélée positive pour 2 patients (2/39) présentant une hépatite C active. La détection de l’ARN VHC dans la fraction de spermatozoïdes mobiles obtenue après sélection en gradient de densité s’est révélée négative dans tous les cas.
Abstract
Medical assistance to procreation in a couple where one or both parents has hepatitis C viral infection (HCV) raises the issue of the transmission of the infection to the baby and/or of possible contamination of both the technicians and the gemetes or embryos from virus-free parents in the laboratory. It becomes essential to assess transmission risk in Assisted Reproductive Techniques (ART) in order to clearly define the management of couples according to their viral status. To define the HCV transmissibility risk in ART related to the presence of virus in semen from infected infertile men, RNA HCV-detection was performed in sera, and semen and sperm fractions obtained after Percoll gradient centrifugation. RNA HCV was detected in 5% (2/39) of the semen tested: in the raw semen, in the seminal fluid and in the cell pellet but never after Percoll selection. According to these results, we suggest a strategy for HCV infected infertile men who need ART.
References
ABUSHEIKHA, N., AKAGBOSU, F., MARCUS, S., COUSINS, C., BRINSDEN, P.: Viral screening and Assisted Conception Treatment — The Bourn Hall Experience. J. Assist. Reprod. Genet. 1999, 16, 337–339.
CALDWELL, S. H., SUE, M., BOWDEN, J. H., DICKSON, R.C., DRISCOLL, C.J., YEATON, P., STEVENSON, W.C., ISHITANI, M.B., MC CULLOUGH, C.S., PRUETT, T.L., LOVELL, M.A.: Hepatitis C virus in body fluids after liver transplantation. Liver Transpl. Surg. 1996, 2 (2), 124–129.
DE VOS, A., NAGY, Z.P., VAN DE VELDE, H., JORIS, H., BOCKEN, G., VAN STEIRTEGHEM, A. Percoll gradient centrifugation can be omitted in sperm preparation for intracytoplasmic sperm injection. Hum. Reprod. 1997, 12, 1980–1984.
FIORE, R. J., POTENZA, D., MONNO, L., APICE, A., DISTEPHANO, M., GIANNELLI, A., LAGRASTA, L., ROMANELLI, C., DIBARI, C., PASTORE, G.: Detection of HCV RNA in serum and seminal fluid from HIV — 1 co — infected intravenous drug addiets. J. Med. Virol. 1995, 46, 364–367.
FRIED, M. W., SHINDO, M., FONG, T., FOX, P. C., HOFFNAGLE, J.H., DI BISCEGLIE, A.: Absence of hepatitis C viral RNA from saliva and semen of patients with chronic hepatitis C. Gastroenterology, 1992, 102, 1406–1308.
GILLET, P., HALLAM, N., MOK, J. Vertical transmission of hepatitis C virus infection. Scand. J. Infect. Dis., 1996, 28, 549–552.
HSU, H.H., WRIGHT, T., L., LUBA, D., MARTIN, M., FEINSTONE, S.M., GARCIA, G., GREEMNBERG, H.B.: Failure to detect hepatitis C virus genome in human secretions with the polymerase chain reaction. Hepatology, 1991, 14, 763–767.
KIYOSAWA, K., SODEYAMA, T., TANAKA, E.: Hepatitis C in hospital employees with needlestick injuries. Ann. Intern. Med. 1991, 115, 367–369.
KOTWAL, G.J., RUSTGI, V.K., BAROUDY, B.M.: Detection of hepatitis C virus specific antigens in semen from non A, non B hepatitis patients. Dig. Dis. Sci., 1992, 35, 641–644.
KOTWAL, G.J.: Routine laboratory diagnosis of hepatitis C virus infection. J. Hepatol. 1993, 17, Suppl. 3, S83-S89.
LEVY, R., NAJIOULIAH, F., KEPPI, B., THOUVENOT, D., BOSSHARD, S., LORNAGE, J., LINA, B., GUERIN, J.F., AYMARD, M.: Detection of cytomegalovirus in semen from a population of men seeking infertility evaluation. Fertil. Steril. 1997, 68, 820–826.
LEVY, R., LAYANI-MILON, M.P., GISCARD D’ESTAING, S., NAJIOULLAH, F., LORNAGE, J., AYMARD, M. AND LINA, B. Screening for chlamydia trachomatis and Ureaplasma urealyticum infection in semen from asymptomatic male partners of infertile couples prior to in vitro fertilization. Int. J. Androl., 1999, 22, 113–118.
LIOU, T., CHANG, T.T., YOUNG, K.C., LIN, X.Z., LIN, C.Y., WU, H.L.: Detection of HCV RNA in saliva, urine, seminal fluid and ascites. J. Med. Virol. 1992, 37, 197–202.
LIU, F.H., TIAN, G.S., FU, X.X.: Detection of plus and minus strand hepatitis C virus RNA in peripheral blood mononuclear cells and spermatid, Abstract, Chinese Medical Journal, 1994, 74 (5), 284–6.
MASSEY E.J., DASANI, H., JONES, P., SALEEM, A.K.N.: Storage facility exists for sperm from patients positive for antibody to hepatitis C virus. B.M.J. 1996, 313: 1078.
MC KEE, T.A., AVERY, S., MAJD, A., BRINDSEN, P.R.: Risks for transmission of hepatitis C virus during artificial insemination. Fertil. Steril. 1996, 66 (1): 161–163.
NUMATA, N., OHORI, H., HAYAKAWA, Y., SAITOH, Y., TSUNODA, A., KANNO, A.: Demonstration of hepatitis C virus genome in saliva and urine of patients with type C hepatitis: usefulness of the single round polymerase chain reaction method for detection of the HCV genome. J. Med. Virol. 1993, 41: 120–128.
OHTO, H., TERAZAWA, S., SASAKI, N., SASAKI, N., HINO, K., ISHIWATA, C., KAKO, M., UJIIE, N., ENDO, C., MATSUI, A., OKAMOTO, H., MISHIRO, S.: Transmission of hepatitis C virus from mothers to infants. New Engl J Med 1994, 330: 744–750.
Roudot-Thoraval, F., Pawlotsky, J.M., Thiers, V., DESFORGES, L., GIROLLET, P.P., GUILLOT, F., HURAUX C., AUMONT, P., BRECHOT, C., DHUMEAUX, D.: Lack of transmission of hepatitis C virus in human immunodeficiency virus seronegative women: a prospective study with hepatitis C virus RNA testing. Hepatology, 1993, 17, 772–777.
SEMPRINI, A.E., PERSICO, T., THIERS, V., ONETA, M., TUVERI, R., SERAFINI, P., BOSCHINI, A., GIUNTELLI, S., PARDI, G., BRECHOT, C.: Absence of hepatitis C virus and detection of hepatitis G virus/ GB virus C RNA sequences in the semen of infected men. J. Infect. Dis. 1998, 177 (4), 848–854.
TACHET, A., DULIOUST, E., SALMON, D., DE ALMEIDA, M., RIVALLAND, S., FINKIELSZTEJN, L., HEARD, I., JOUANNET, P., SICARD ROUZIOUX, C.: Detection and quantification of HIV-1 in semen: identification of a subpopulation of men at high potential risk of viral sexual transmission. AIDS, 1999, 7, 823–831.
TANG, Z., YANG, D., HAO, L., TANG, Z., HUANG, Y., WANG, S.: Detection and significance of HCV RNA in saliva, seminal fluid and vaginal discharge in patients with hepatitis C. J. Tongji Med. Univ. 1996, 16 (1), 11–13.
TERADA, S., KAWANISHI, K., KATAYAMA, K.: Minimal hepatitis C infectivity in semen. Annals Intern. Med., 1992, 117, 171–172.
YOUNG, K., CHANG, T., LIOU, T., WU, H.: Detection of hepatitis C virus RNA in peripheral blood mononuclear cells and in saliva. J. Med. Virol., 1993, 41, 55–60.
World Health Organization (1992) WHO Laboratory Manual for the Examination of Human Semen and Sperm — Cervical Mucus Interaction. Cambridge University Press.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Levy, R., Tardy, J.C., Bourlet, T. et al. Risque viral lié au virus de l’hépatite C en AMP. Androl. 10, 58–65 (2000). https://doi.org/10.1007/BF03035224
Issue Date:
DOI: https://doi.org/10.1007/BF03035224